The 2 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 72.50, with a high estimate of 75.00 and a low estimate of 70.00. The median estimate represents a -8.76% decrease from the last price of 79.47.
The current consensus among 2 polled investment analysts is to Hold stock in USANA Health Sciences Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.99
Reporting Date Feb 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.